Systematic Review

Published on 18 Apr 2024

Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 treatments: a systematic review and meta-analysis of 19,139 multiple sclerosis patients

in Multiple Sclerosis and Neuroimmunology

Anas Elgenidy
Nagham Nader Abdelhalim
Mohammed Al-mahdi Al-kurdi
Lobna A. Mohamed
Mohamed M. Ghoneim
Ahmed Wagdy Fathy
Hazem Khaled Hassaan
Ahmed Anan
Omar Alomari

Frontiers in Neurology

doi 10.3389/fneur.2024.1380654

3,119 views

Case Report

Published on 18 Apr 2024

Case report: Headache as the sole neurological symptom in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy

in Multiple Sclerosis and Neuroimmunology

Eslam Shosha
Colleen Connolly
Adrian Budhram

Frontiers in Neurology

doi 10.3389/fneur.2024.1366263

1,304 views

Case Report

Published on 18 Apr 2024

Case report: A case of anti-glycine receptor encephalomyelitis triggered by post-transplant or COVID-19 infection?

in Multiple Sclerosis and Neuroimmunology

Zhengxue Zhang
Xiang Zhang
Mingming Dai
Yingying Wu
Yong You

Frontiers in Neurology

doi 10.3389/fneur.2024.1356691

1,083 views

Case Report

Published on 16 Apr 2024

Case report: Transition from anti-CD20 therapy to inebilizumab for 14 cases of neuromyelitis optica spectrum disorder

in Multiple Sclerosis and Neuroimmunology

Benjamin Osborne
Gabriela Romanow
J. Michael Hemphill
Myassar Zarif
Tracy DeAngelis
Tyler Kaplan
Unsong Oh
Johnathan Pinkhasov
Kristina Patterson
Michael Levy

Frontiers in Neurology

doi 10.3389/fneur.2024.1352779

4,076 views

Original Research

Published on 16 Apr 2024

Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MS

in Multiple Sclerosis and Neuroimmunology

Tobias Zrzavy
Kerstin Rieder
Viktoria Wuketich
Renate Thalhammer
Helmuth Haslacher
Patrick Altmann
Barbara Kornek
Nik Krajnc
Tobias Monschein
Christiane Schmied

Frontiers in Neurology

doi 10.3389/fneur.2024.1388941

1,091 views
1 citation

Original Research

Published on 10 Apr 2024

People with newly diagnosed multiple sclerosis benefit from a complex preventative intervention—a single group prospective study with follow up

in Multiple Sclerosis and Neuroimmunology

Natália Hrušková
Kateřina Berchová Bímová
Angela Davies Smith
Tereza Škodová
Marie Bičíková
Lucie Kolátorová
Ivana Štětkářová
Ľuba Brožek
Alena Javůrková
Gabriela Angelová

Frontiers in Neurology

doi 10.3389/fneur.2024.1373401

919 views

Systematic Review

Published on 10 Apr 2024

Risk of secondary immune thrombocytopenia following alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Yuying Sun
Zhimei Liu
Jianguo Yang
Qingqing Jia
Jinglong Sun
Lei Wang
Fengjiao Liang
Shiyuan Song
Kaixi Wang
Xia Zhou

Frontiers in Neurology

doi 10.3389/fneur.2024.1375615

1,245 views

Mini Review

Published on 09 Apr 2024

A rapid review of differences in cerebrospinal neurofilament light levels in clinical subtypes of progressive multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Haritha L. Desu
Katherine M. Sawicka
Emily Wuerch
Vanessa Kitchin
Jacqueline A. Quandt

Frontiers in Neurology

doi 10.3389/fneur.2024.1382468

1,263 views

Original Research

Published on 08 Apr 2024

Primary CNS vasculitis: insights into clinical, neuropathological, and neuroradiological characteristics

in Multiple Sclerosis and Neuroimmunology

Tahani Saker Sheikh
Ayal Rozenberg
Goni Merhav
Alla Shifrin
Polina Stein
Shahar Shelly

Frontiers in Neurology

doi 10.3389/fneur.2024.1363985

1,814 views

Study Protocol

Published on 04 Apr 2024

Prospective observational study to evaluate treatment satisfaction and effectiveness in patients with relapsing multiple sclerosis starting cladribine tablets (CLADREAL) in Italy

in Multiple Sclerosis and Neuroimmunology

Massimo Filippi
Laura Ferrè
Chiara Zanetta
Caterina Rizzi
Gabriella Pessina
Francesco Assogna
Maria A. Rocca

Frontiers in Neurology

doi 10.3389/fneur.2024.1379712

1,871 views

Original Research

Published on 22 Mar 2024

Clinical characteristics and MRI features of autoimmune glial fibrillary acidic protein astrocytopathy: a case series of 34 patients

in Multiple Sclerosis and Neuroimmunology

Gaotan Ke
Si Jian
Tingxin Yang
Xu Zhao

Frontiers in Neurology

doi 10.3389/fneur.2024.1375971

2,451 views
3 citations

Case Report

Published on 20 Mar 2024

Gait instability, ophthalmoplegia, and chorea with orofacial dyskinesia in a man with anti-Ri antibodies: a case report

in Multiple Sclerosis and Neuroimmunology

Mukuto Shioda
Hiroaki Fujita
Hiroki Onuma
Hirotaka Sakuramoto
Mai Hamaguchi
Keisuke Suzuki

Frontiers in Neurology

doi 10.3389/fneur.2024.1359781

1,140 views

Brief Research Report

Published on 14 Mar 2024

Myelin oligodendrocyte glycoprotein antibody titers by fixed cell-based assay: positive predictive value and impact of sample collection timing

in Multiple Sclerosis and Neuroimmunology

Adrian Budhram
Dalia L. Rotstein
Liju Yang
E. Ann Yeh

Frontiers in Neurology

doi 10.3389/fneur.2024.1380541

1,686 views
1 citation

Case Report

Published on 11 Mar 2024

Probable secondary hemophagocytic lymphohistiocytosis manifesting as central nervous system lesions after COVID-19 vaccination: a case report

in Multiple Sclerosis and Neuroimmunology

Ju Hye Kim
Ji Yeon Chung
Jeong Bin Bong

Frontiers in Neurology

doi 10.3389/fneur.2024.1363072

1,697 views
3 citations

Systematic Review

Published on 11 Mar 2024

Disease-modifying therapy in progressive multiple sclerosis: a systematic review and network meta-analysis of randomized controlled trials

in Multiple Sclerosis and Neuroimmunology

Xin Wu
Shixin Wang
Tao Xue
Xin Tan
Jiaxuan Li
Zhouqing Chen
Zhong Wang

Frontiers in Neurology

doi 10.3389/fneur.2024.1295770

3,233 views
1 citation

Case Report

Published on 29 Feb 2024

Successful switch to ofatumumab after liver injury associated with ocrelizumab treatment in multiple sclerosis: a case report

in Multiple Sclerosis and Neuroimmunology

Alice Mariottini
Alessandro Barilaro
Antonio Lotti
Fabio Marra
Luca Massacesi

Frontiers in Neurology

doi 10.3389/fneur.2024.1363493

2,427 views
1 citation

Navigation group

Articles

Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 treatments: a systematic review and meta-analysis of 19,139 multiple sclerosis patients

Case report: Headache as the sole neurological symptom in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy

Case report: A case of anti-glycine receptor encephalomyelitis triggered by post-transplant or COVID-19 infection?

Case report: Transition from anti-CD20 therapy to inebilizumab for 14 cases of neuromyelitis optica spectrum disorder

Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MS

People with newly diagnosed multiple sclerosis benefit from a complex preventative intervention—a single group prospective study with follow up

Risk of secondary immune thrombocytopenia following alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis

A rapid review of differences in cerebrospinal neurofilament light levels in clinical subtypes of progressive multiple sclerosis

Primary CNS vasculitis: insights into clinical, neuropathological, and neuroradiological characteristics

Prospective observational study to evaluate treatment satisfaction and effectiveness in patients with relapsing multiple sclerosis starting cladribine tablets (CLADREAL) in Italy

Clinical characteristics and MRI features of autoimmune glial fibrillary acidic protein astrocytopathy: a case series of 34 patients

Gait instability, ophthalmoplegia, and chorea with orofacial dyskinesia in a man with anti-Ri antibodies: a case report

Myelin oligodendrocyte glycoprotein antibody titers by fixed cell-based assay: positive predictive value and impact of sample collection timing

Probable secondary hemophagocytic lymphohistiocytosis manifesting as central nervous system lesions after COVID-19 vaccination: a case report

Disease-modifying therapy in progressive multiple sclerosis: a systematic review and network meta-analysis of randomized controlled trials

Successful switch to ofatumumab after liver injury associated with ocrelizumab treatment in multiple sclerosis: a case report